The vaccination with CoronaVac that is produced by the Chinese company Sinovac does not cause infection with COVID-19. The testing of this vaccine in Brazil, Turkey and Indonesia showed that it is safe, Ninel Revenco, coordinator of the national COVID-19 vaccination campaign, stated in a news conference, being quoted by IPN.

The vaccine made by Sinovac was approved in 19 countries, inclining EU member states. Ninel Revenco noted that the vaccine was created based on an inactive COVID-19 virus. Clinical data show the vaccine prevents serious forms of infection, hospitalization and death. At the same time, the vaccine is 50% efficient in preventing the mild course of the disease, which means that half of those who were immunized with Sinovac can develop mild forms of infection.

Ninel Revenco also said that all the existing vaccines against COVID-19 are safe and they should not be compared in terms of their efficiency.

The Ministry of Health, Labor and Social Protection on April 9 said that it was considering the possibility of buying 400,000 doses of CoronaVac vaccine produced by Sinovac. The opposition MPs criticized the Moldovans authorities’ intention to purchase 400,000 doses of CoronaVac vaccine. According to them, the vaccine has a doubtful reputation that endangers the people’s health. The parliamentary opposition said they are waiting for acting Prime Minister Aureliu Ciocoi to come to Parliament to shed light on the issue.